COMPARATIVE ANALYSIS OF THE INDICATOR PROPORTION OF PREGNANT WOMEN WHO WERE TESTED FOR HIV AND SYPHILIS BY THE INDICATOR PANELS OF THE SECRETARY OF PRIMARY HEALTH CARE IN A CITY IN WESTERN PARANÁ

Abstract

Pregnancy is a physiological process that, for it to occur in the best possible way, it is necessary that the pregnant woman does prenatal care properly, and it is the responsibility of the family health team to ensure that she gets all the necessary tests and care. In view of this, the Ministry of Health has a series of health indicators that serve to observe how health care is being provided, and one of them is the proportion of pregnant women who have been tested for HIV and syphilis. To better analyze the data, the Health Indicators Panels that are part of the Previne Brazil Program were created to change the way that the distribution of payment, the indicators will serve as a basis for the transfer of funds by performance, which encourages a more quality care. The objective of this research is to analyze quantitatively the proportion of pregnant women who have been tested for HIV and syphilis in primary care and that the data are available in the Indicators Panels of the Ministry of Primary Care from 2018 to 2022. It can be observed that before it was mandatory to put the data in the platform, the percentages of the indicator were low, but after 2021 they increased significantly - which may indicate that the reason for the low percentages before was because of not putting the data in the platform; the North and Northeast regions always present a higher percentage than the others, which indicates that from the beginning they participated in the program. Therefore, we conclude that feeding the data from the Indicator Panels is relevant since it shows how the health care is being carried out and the payment for performance encourages the teams to work more assertively. The indicator proportion of pregnant women who have been tested for HIV and syphilis is important, since it ensures a prenatal care that reduces maternal and fetal mortality.